Literature DB >> 15614843

The influence of prenatal diagnosis on postnatal outcome in patients with structural congenital heart disease.

Robert S Yates1.   

Abstract

Examination of the fetal heart has become an established part of mid-trimester anomaly scanning. Along side this has emerged the ability to diagnose congenital heart disease in the fetus with accuracy. Despite this, the development of screening programmes to look for fetal cardiac disease has only been partially successful. Furthermore, when detected, there seems to be little survival advantage associated with prenatal diagnosis. Demonstrating such an advantage is complicated by the nature of fetal cardiac disease, which tends to be severe and is often associated with extra-cardiac abnormalities. More selective studies, mostly involving small numbers of cases, are now beginning to demonstrate both improved survival and reduced morbidity in prenatally diagnosed infants presenting to cardiac intensive care units compared to those with a postnatal diagnosis. 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15614843     DOI: 10.1002/pd.1072

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  7 in total

1.  Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006.

Authors:  Suzanne M Gilboa; Jason L Salemi; Wendy N Nembhard; David E Fixler; Adolfo Correa
Journal:  Circulation       Date:  2010-11-22       Impact factor: 29.690

2.  Association of Prenatal Diagnosis of Critical Congenital Heart Disease With Postnatal Brain Development and the Risk of Brain Injury.

Authors:  Shabnam Peyvandi; Veronica De Santiago; Elavazhagan Chakkarapani; Vann Chau; Andrew Campbell; Kenneth J Poskitt; Duan Xu; A James Barkovich; Steven Miller; Patrick McQuillen
Journal:  JAMA Pediatr       Date:  2016-04-04       Impact factor: 16.193

3.  Morphological features of complex congenital cardiovascular anomalies in fetuses: as evaluated by cast models.

Authors:  Hai-Yan Cao; Yu Wang; Liu Hong; Wei Han; Lin He; Ben-Cai Song; Yun-Fei Hu; Yuan Peng; Bin Wang; Jing Wang; Wen-Ying Huang; Jing Deng; Ming-Xing Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

4.  Pregnancy and contraception in young women with congenital heart disease: General considerations.

Authors:  Rachel M Wald; Mathew Sermer; Jack M Colman
Journal:  Paediatr Child Health       Date:  2011-04       Impact factor: 2.253

5.  Chromosomal anomalies influence parental treatment decisions in relation to prenatally diagnosed congenital heart disease.

Authors:  Sinai C Zyblewski; Elizabeth G Hill; Girish Shirali; Andrew Atz; Geoffrey Forbus; Javier Gonzalez; Anthony Hlavacek
Journal:  Pediatr Cardiol       Date:  2009-08-25       Impact factor: 1.655

6.  Minimizing the risk of preoperative brain injury in neonates with aortic arch obstruction.

Authors:  Selma O Algra; Felix Haas; Kenneth J Poskitt; Floris Groenendaal; Antonius N J Schouten; Nicolaas J G Jansen; Anthony Azakie; Sanjiv Gandhi; Andrew Campbell; Steven P Miller; Patrick S McQuillen; Linda S de Vries
Journal:  J Pediatr       Date:  2014-10-11       Impact factor: 4.406

7.  The significance of an integrated management mode of prenatal diagnosis-postnatal treatment for critical congenital heart disease in newborns.

Authors:  Xiaohui Zhang; Shaoru He; Yumei Liu; Jing Zhong; Yunxia Sun; Manli Zheng; Juan Gui; Ruixi Wang; Bowen Feng; Jianling Mo; Minqiao Jian; Caisheng Liu; Yijing Liang
Journal:  Cardiovasc Diagn Ther       Date:  2021-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.